These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25829808)

  • 1. Addition of N-terminal pro-B-type natriuretic peptide levels to electrocardiography criteria for detection of left ventricular hypertrophy: the ARIRANG study.
    Ahn MS; Yoo BS; Lee JH; Lee JW; Youn YJ; Ahn SG; Kim JY; Lee SH; Yoon J; Park JK; Ahn SV; Choi E
    J Korean Med Sci; 2015 Apr; 30(4):407-13. PubMed ID: 25829808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of highly sensitive troponin T and N-terminal pro-B-type natriuretic peptide to electrocardiography for detection of left ventricular hypertrophy: results from the Dallas Heart Study.
    Martinez-Rumayor AA; de Lemos JA; Rohatgi AK; Ayers CR; Powell-Wiley TM; Lakoski SG; Berry JD; Khera A; Das SR
    Hypertension; 2013 Jan; 61(1):105-11. PubMed ID: 23150502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological, electrical and echocardiographic indices versus cardiac magnetic resonance imaging in diagnosing left ventricular hypertrophy.
    Courand PY; Gaudebout N; Mouly-Bertin C; Thomson V; Fauvel JP; Bricca G; Lantelme P
    Hypertens Res; 2014 May; 37(5):444-51. PubMed ID: 24132010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
    Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community.
    Somaratne JB; Whalley GA; Poppe KK; ter Bals MM; Wadams G; Pearl A; Bagg W; Doughty RN
    Cardiovasc Diabetol; 2011 Apr; 10():29. PubMed ID: 21492425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension.
    Mahn JJ; Dubey E; Brody A; Welch R; Zalenski R; Flack JM; Ference B; Levy PD
    Acad Emerg Med; 2014 Sep; 21(9):996-1002. PubMed ID: 25269580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic accuracy of NT-proBNP compared with electrocardiography in detecting left ventricular hypertrophy of hypertensive origin].
    Andrade H; Morillas P; Castillo J; Roldán J; Mateo I; Agudo P; Quiles J; Bertomeu-Martínez V
    Rev Esp Cardiol; 2011 Oct; 64(10):939-41. PubMed ID: 21664755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A; Adebiyi AA; Aje A; Oladapo OO; Falase AO
    Ethn Dis; 2005; 15(4):578-84. PubMed ID: 16259479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
    Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI.
    Alfakih K; Walters K; Jones T; Ridgway J; Hall AS; Sivananthan M
    Hypertension; 2004 Aug; 44(2):175-9. PubMed ID: 15226274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction.
    Goetze JP; Mogelvang R; Maage L; Scharling H; Schnohr P; Sogaard P; Rehfeld JF; Jensen JS
    Eur Heart J; 2006 Dec; 27(24):3004-10. PubMed ID: 17118955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.
    de Lemos JA; McGuire DK; Khera A; Das SR; Murphy SA; Omland T; Drazner MH
    Am Heart J; 2009 Apr; 157(4):746-53.e2. PubMed ID: 19332205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of NT-proBNP level for diagnosing left ventricular hypertrophy in hypertensive patients. A cardiac magnetic resonance study.
    Morillas P; Castillo J; Quiles J; Nuñez D; Guillén S; Maceira A; Rivera M; Bertomeu V
    Rev Esp Cardiol; 2008 Sep; 61(9):972-5. PubMed ID: 18775240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consistency of left ventricular hypertrophy diagnosed by electrocardiography and echocardiography: the Northern Shanghai Study.
    Zhang W; Zhou Y; Bai B; Yu S; Xiong J; Chi C; Teliewubai J; Li J; Blacher J; Zhang Y; Xu Y
    Clin Interv Aging; 2019; 14():549-556. PubMed ID: 30880935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and characterization of left ventricular hypertrophy by computerized acoustic cardiography, brain natriuretic peptide, and electrocardiography.
    Rogers RK; Collins SP; Kontos MC; Zuber M; Arand P; Michaels AD
    J Electrocardiol; 2008; 41(6):518-25. PubMed ID: 18804784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of ECG criteria for the diagnosis of left ventricular hypertrophy: a comparison with magnetic resonance imaging.
    Krittayaphong R; Nomsawadi V; Muenkaew M; Miniphan M; Yindeengam A; Udompunturak S
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S124-32. PubMed ID: 23590032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
    Costello-Boerrigter LC; Boerrigter G; Redfield MM; Rodeheffer RJ; Urban LH; Mahoney DW; Jacobsen SJ; Heublein DM; Burnett JC
    J Am Coll Cardiol; 2006 Jan; 47(2):345-53. PubMed ID: 16412859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
    Tsiachris D; Chrysohoou C; Oikonomou E; Lazaros G; Dimitriadis K; Maragiannis D; Roussos D; Andreou I; Tsantilas A; Christoforatou E; Pitsavos C; Panagiotakos D; Stefanadis C
    J Hypertens; 2011 Aug; 29(8):1624-32. PubMed ID: 21610511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic potential of cardiac natriuretic peptides in dialysis patients.
    Mallamaci F; Zoccali C; Tripepi G; Benedetto FA; Parlongo S; Cataliotti A; Cutrupi S; Giacone G; Bellanuova I; Stancanelli B; Malatino LS;
    Kidney Int; 2001 Apr; 59(4):1559-66. PubMed ID: 11260421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
    Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.